BACKGROUND: The platelet alpha2beta1 integrin functions as both an adhesion and signaling receptor upon exposure to collagen. Recent studies have indicated that alpha2beta1 function can be activated via inside-out signaling, similar to the prototypical platelet integrin alphaIIbbeta3. However, signaling molecules that regulate alpha2beta1 activation in platelets are not well defined. A strong candidate molecule is the small GTPase Rap1b, the dominant platelet isoform of Rap1, which regulates alphaIIbbeta3 activation. OBJECTIVES: We hypothesized that Rap1b positively regulates alpha2beta1 during agonist-induced platelet activation. METHODS: To test whether Rap1b activates alpha2beta1 downstream of glycoprotein (GP)VI or other platelet receptors, we stimulated platelets purified from Rap1b-/- or wild-type mice with diverse agonists and measured alpha2beta1 activation using fluorescein isothiocyanate-labeled monomeric collagen. We also examined the role of Rap1b in outside-in signaling pathways by analyzing adhesion and spreading of Rap1b-/- or wild-type platelets on monomeric, immobilized collagen. Finally, we monitored the activation status of related Rap GTPases to detect changes in signaling pathways potentially associated with Rap1b-mediated events. RESULTS: Rap1b-/- platelets displayed comparable ADP-induced or thrombin-induced alpha2beta1 activation as wild-type platelets, but reduced convulxin-dependent alpha2beta1 activation. Rap1b-/- platelets exhibited increased spreading on immobilized collagen but similar adhesion to immobilized collagen compared to wild-type platelets. Rap1b-/- platelets also showed Rap1a and Rap2 activation upon agonist stimulation, possibly revealing functional compensation among Rap family members. CONCLUSIONS: Rap1b is required for maximal GPVI-induced but not ADP-induced activation of alpha2beta1 in murine platelets.
BACKGROUND: The platelet alpha2beta1 integrin functions as both an adhesion and signaling receptor upon exposure to collagen. Recent studies have indicated that alpha2beta1 function can be activated via inside-out signaling, similar to the prototypical platelet integrin alphaIIbbeta3. However, signaling molecules that regulate alpha2beta1 activation in platelets are not well defined. A strong candidate molecule is the small GTPase Rap1b, the dominant platelet isoform of Rap1, which regulates alphaIIbbeta3 activation. OBJECTIVES: We hypothesized that Rap1b positively regulates alpha2beta1 during agonist-induced platelet activation. METHODS: To test whether Rap1b activates alpha2beta1 downstream of glycoprotein (GP)VI or other platelet receptors, we stimulated platelets purified from Rap1b-/- or wild-type mice with diverse agonists and measured alpha2beta1 activation using fluorescein isothiocyanate-labeled monomeric collagen. We also examined the role of Rap1b in outside-in signaling pathways by analyzing adhesion and spreading of Rap1b-/- or wild-type platelets on monomeric, immobilized collagen. Finally, we monitored the activation status of related Rap GTPases to detect changes in signaling pathways potentially associated with Rap1b-mediated events. RESULTS:Rap1b-/- platelets displayed comparable ADP-induced or thrombin-induced alpha2beta1 activation as wild-type platelets, but reduced convulxin-dependent alpha2beta1 activation. Rap1b-/- platelets exhibited increased spreading on immobilized collagen but similar adhesion to immobilized collagen compared to wild-type platelets. Rap1b-/- platelets also showed Rap1a and Rap2 activation upon agonist stimulation, possibly revealing functional compensation among Rap family members. CONCLUSIONS:Rap1b is required for maximal GPVI-induced but not ADP-induced activation of alpha2beta1 in murine platelets.
Authors: B Franke; M van Triest; K M de Bruijn; G van Willigen; H K Nieuwenhuis; C Negrier; J W Akkerman; J L Bos Journal: Mol Cell Biol Date: 2000-02 Impact factor: 4.272
Authors: Olaf Holtkötter; Bernhard Nieswandt; Neil Smyth; Werner Müller; Martin Hafner; Valerie Schulte; Thomas Krieg; Beate Eckes Journal: J Biol Chem Date: 2002-01-11 Impact factor: 5.157
Authors: B Nieswandt; C Brakebusch; W Bergmeier; V Schulte; D Bouvard; R Mokhtari-Nejad; T Lindhout; J W Heemskerk; H Zirngibl; R Fässler Journal: EMBO J Date: 2001-05-01 Impact factor: 11.598
Authors: B Nieswandt; V Schulte; W Bergmeier; R Mokhtari-Nejad; K Rackebrandt; J P Cazenave; P Ohlmann; C Gachet; H Zirngibl Journal: J Exp Med Date: 2001-02-19 Impact factor: 14.307
Authors: Guoying Zhang; Binggang Xiang; Shaojing Ye; Magdalena Chrzanowska-Wodnicka; Andrew J Morris; T Kent Gartner; Sidney W Whiteheart; Gilbert C White; Susan S Smyth; Zhenyu Li Journal: J Biol Chem Date: 2011-09-22 Impact factor: 5.157
Authors: Stephen P Holly; Jae Won Chang; Weiwei Li; Sherry Niessen; Ryan M Phillips; Raymond Piatt; Justin L Black; Matthew C Smith; Yacine Boulaftali; Andrew S Weyrich; Wolfgang Bergmeier; Benjamin F Cravatt; Leslie V Parise Journal: Chem Biol Date: 2013-08-29
Authors: Andrew D Johnson; Lisa R Yanek; Ming-Huei Chen; Nauder Faraday; Martin G Larson; Geoffrey Tofler; Shiow J Lin; Aldi T Kraja; Michael A Province; Qiong Yang; Diane M Becker; Christopher J O'Donnell; Lewis C Becker Journal: Nat Genet Date: 2010-06-06 Impact factor: 38.330
Authors: Barbara Ulmasov; Jonathan Bruno; Kiyoko Oshima; Yao-Wen Cheng; Stephen P Holly; Leslie V Parise; Terrance M Egan; John C Edwards Journal: Physiol Rep Date: 2017-03